Inflammatory Macrophages Promotes Development of Diabetic Encephalopathy

• Main Authors: Beiyun Wang, Ya Miao, Zhe Zhao, Yuan Zhong
• Format: Article
• Language: English
• Published: Cell Physiol Biochem Press GmbH & Co KG 2015-06-01
• Series: Cellular Physiology and Biochemistry
• Subjects: Diabetic encephalopathy; Streptozotocin (STZ); Diabetes; Inflammatory macrophages
• Online Access: http://www.karger.com/Article/FullText/430285
• ISSN: 1015-8987; 1421-9778

Background/Aims: Diabetes and Alzheimer's disease are often associated with each other, whereas the relationship between two diseases is ill-defined. Although hyperglycemia during diabetes is a major cause of encephalopathy, diabetes may also cause chronic inflammatory complications including peripheral neuropathy. Hence the role and the characteristics of inflammatory macrophages in the development of diabetic encephalopathy need to be clarified. Methods: Diabetes were induced in mice by i.p. injection of streptozotocin (STZ). Two weeks after STZ injection and confirmation of development of diabetes, inflammatory macrophages were eliminated by i.p. injection of 20µg saporin-conjugated antibody against a macrophage surface marker CD11b (saporin-CD11b) twice per week, while a STZ-treated group received injection of rat IgG of same frequency as a control. The effects of macrophage depletion on brain degradation markers, brain malondialdehyde (MDA), catalase, superoxidase anion-positive cells and nitric oxide (NO) were measured. Results: Saporin-CD11b significantly reduced inflammatory macrophages in brain, without affecting mouse blood glucose, serum insulin, glucose responses and beta cell mass. However, reduced brain macrophages significantly inhibited the STZ-induced decreases in brain MDA, catalase and superoxidase anion-positive cells, and the STZ-induced decreases in brain NO. Conclusion: Inflammatory macrophages may promote development of diabetic encephalopathy.